Autek China Inc. (SHE:300595)

Market Cap	12.70B +3.0%
Revenue (ttm)	1.84B +0.8%
Net Income	465.44M -13.7%
EPS	0.52 -13.6%
Shares Out	895.29M
PE Ratio	27.18
Forward PE	18.80
Dividend	0.15 (1.07%)
Ex-Dividend Date	Nov 5, 2025

Volume	7,595,307
Average Volume	9,682,868
Open	14.11
Previous Close	14.18
Day's Range	14.11 - 14.29
52-Week Range	13.76 - 19.98
Beta	0.68
RSI	45.34
Earnings Date	Aug 20, 2026

About Autek China

Autek China Inc. engages in the research and development, production, and sale of optometry products and related supporting products in China. The company offers rigid contact lenses, rigid lens care products, myopia control products other than rigid glasses, visual function training products, dry eye/eye strain/presbyopia/accommodative hypoplasia treatment products, and eye health products. It also provides ophthalmic and optometry medical devices. Autek China Inc. was incorporated in 2000 and is based in Hefei, China.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 3,752
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300595

Financial Performance

In 2025, Autek China's revenue was 1.86 billion, an increase of 2.62% compared to the previous year's 1.81 billion. Earnings were 479.52 million, a decrease of -16.20%.